PCV54 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS AGED OVER 75 YEARS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY
May 1, 2009, 00:00
10.1016/S1098-3015(10)73816-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)73816-X/fulltext
Title :
PCV54 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS AGED OVER 75 YEARS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73816-X&doi=10.1016/S1098-3015(10)73816-X
First page :
Section Title :
Open access? :
No
Section Order :
289